Hypogammaglobulinemia

Hypogammaglobulinemia
ICD-10	D80.0-D80.1
ICD-9	279.00
DiseasesDB	6426
MedlinePlus	001307
eMedicine	med/1120  ped/54
MeSH	D000361

WikiDoc Resources for Hypogammaglobulinemia
Articles
Most recent articles on Hypogammaglobulinemia Most cited articles on Hypogammaglobulinemia Review articles on Hypogammaglobulinemia Articles on Hypogammaglobulinemia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hypogammaglobulinemia Images of Hypogammaglobulinemia Photos of Hypogammaglobulinemia Podcasts & MP3s on Hypogammaglobulinemia Videos on Hypogammaglobulinemia
Evidence Based Medicine
Cochrane Collaboration on Hypogammaglobulinemia Bandolier on Hypogammaglobulinemia TRIP on Hypogammaglobulinemia
Clinical Trials
Ongoing Trials on Hypogammaglobulinemia at Clinical Trials.gov Trial results on Hypogammaglobulinemia Clinical Trials on Hypogammaglobulinemia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hypogammaglobulinemia NICE Guidance on Hypogammaglobulinemia NHS PRODIGY Guidance FDA on Hypogammaglobulinemia CDC on Hypogammaglobulinemia
Books
Books on Hypogammaglobulinemia
News
Hypogammaglobulinemia in the news Be alerted to news on Hypogammaglobulinemia News trends on Hypogammaglobulinemia
Commentary
Blogs on Hypogammaglobulinemia
Definitions
Definitions of Hypogammaglobulinemia
Patient Resources / Community
Patient resources on Hypogammaglobulinemia Discussion groups on Hypogammaglobulinemia Patient Handouts on Hypogammaglobulinemia Directions to Hospitals Treating Hypogammaglobulinemia Risk calculators and risk factors for Hypogammaglobulinemia
Healthcare Provider Resources
Symptoms of Hypogammaglobulinemia Causes & Risk Factors for Hypogammaglobulinemia Diagnostic studies for Hypogammaglobulinemia Treatment of Hypogammaglobulinemia
Continuing Medical Education (CME)
CME Programs on Hypogammaglobulinemia
International
Hypogammaglobulinemia en Espanol Hypogammaglobulinemia en Francais
Business
Hypogammaglobulinemia in the Marketplace Patents on Hypogammaglobulinemia
Experimental / Informatics
List of terms related to Hypogammaglobulinemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Synonyms and keywords:

Overview

Hypogammaglobulinemia is a type of primary immune deficiency disease.

Hypogammaglobulinemia is a characteristic of common variable immunodeficiency. "Hypogammaglobulinemia" is largely synonymous with "agammaglobulinemia". When the latter term is used (as in "X-linked agammaglobulinemia") it implies that gamma globulins are not merely reduced, but completely absent. Modern assays have allowed most agammaglobulinemias to be more precisely defined as hypogammaglobulinemias, but the distinction is not usually clinically relevant.

"Hypogammaglobulinemia" is distinguished from dysgammaglobulinemia, which is a reduction in some types of gamma globulins, but not others.

Historical Perspective

• Dr. Robert A Good and March of dimes foundation maintained a close association for a quarter century in the fight against immunodeficiency diseases.
• Immunodeficiency diseases such as ataxia telangiectasia have been described as early as 1920's, wiskott aldrich's during 1930's.
• Between 1950-1965, primary immunodeficiencies affecting all major levels of immune system were first described.

• Use of immunoglobulins for the tretament of hypogammaglobulinemia was practised as early as 1950's.
• Therapeutic results in the use of human serum gamma globulins have been published during the late 1950's.
• Treatment of various infectious diseases with the use of gamma globulins started during the late 1950's. Whooping cough was treated with placental immunoglobulin during the year 1959.

Classification

Type	OMIM	Gene
AGM1	601495	IGHM
AGM2	613500	IGLL1
AGM3	613501	CD79A
AGM4	613502	BLNK
AGM5	613506	LRRC8A
AGM6	612692	CD79B

Pathophysiology

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR

[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Causes

Hypogammaglobulinemia is caused by:

Primary or congenital B-cell disorders	X-linked agammaglobulinemia, Common variable immunodeficiency, transient hypogammaglobulinemia of infancy, IgG subclass deficiency,severe combined immunodeficieny, Wiskott-Aldrich syndrome, Ataxia-telanectasia
Cardiovascular	No underlying causes
Dermatologic	No underlying causes
Drugs	Gold, D- penicillamine, Sulfasalazine, anticonvulsants, glucocorticoids, methotrexate, calcineurin inhibitors, rituximab
Ear Nose Throat	No underlying causes
Endocrine	No underlying causes
Environmental	Ionizing radiation, Toxins
Gastroenterologic	protein losing enteropathy, intestinal lymphangiectasia, Cirrhosis
Hematologic	Thymoma
Iatrogenic	Radiation
Infectious Disease	Herpes, Measles, Mycobacterial, Malaria, helminthic infections
Nutritional / Metabolic	Protein energy malnutrition
Obstetric/Gynecologic	Ovarian cancer
Oncologic	Chronic lymphocytic leukemia, Multiple myeloma, Thymoma
Overdose / Toxicity
Pulmonary	bronchiectasis
Renal / Electrolyte	Nephrotic syndrome, Hemodialysis
Trauma
Urologic	No underlying causes
Miscellaneous

Differentiating Hypogammaglobulinemia from Other Diseases

Hypogammaglobulinemia must be differentiated from Bronchiectasis, complement deficiencies, and cysticfibrosis

Medical condition	Characteristic features
Complement deficiencies	Caused by a genetic defect in one of the genes that code for different complement proteins Constitute about 7-9% of primary immunodeficiencies Deficiency of C1q, C2, C4 tend to be linked with autoimmune diseases. C5-C9 deficiency more prone to meningococcal disease.
Bronchiectasis	Secondary to an infectious process resulting in distortion of conducting bronchi Copious mucopurulent sputum production lasting for months to years Hemoptysis Dyspnea, pleuritic chest pain, wheezing, fever, weight loss
Cystic fibrosis	Glomeruonephritis in most cases resolves after infection subsides Decreased levels of C3 is transient Immunoflouroescence microscopy shows immunoglobulin deposition in poststreptococcal infection
Staphylococcal associated glomerulonephritis	Glomerulonephritis resolves after infection subsides Decreased C3 is transient Immunofluorescence microscopy shows immunoglobulin deposition in staphylococcal associated glomerulonephritis.

Epidemiology and Demographics

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

OR

In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

OR

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.

Patients of all age groups may develop [disease name].

OR

The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

OR

[Disease name] commonly affects individuals younger than/older than [number of years] years of age.

OR

[Chronic disease name] is usually first diagnosed among [age group].

OR

[Acute disease name] commonly affects [age group].

There is no racial predilection to [disease name].

OR

[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

[Disease name] affects men and women equally.

OR

[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

The majority of [disease name] cases are reported in [geographical region].

OR

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Risk Factors

Common risk factors in the development of hypogammaglobulinemia include:

• Family history of a primary immune deficiency disorder
• Medical therapy with drugs such as
  • Rituximab
  • Glucocorticoids
  • Gold
  • Penicillamine
• Bruton's agammaglobulinemia

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Natural History, Complications, and Prognosis

Common complications of hypogammaglobulinemia include:

• Recurrent infections
• Growth retardation( in children)
• Autoimmune disorders
• Increased risk of cancer
• Death due to serious infections

Diagnosis

Diagnostic Study of Choice

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

There are no established criteria for the diagnosis of [disease name].

History and Symptoms

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

Physical Examination

Common physical examination findings of hypogammaglobulinemia include :

• Growth retardation
• Paucity of tonsillar tissue
• Skin: rash, livedo reticularis
• Splenomegaly or hypersplenism in patients with common variable immunodeficiency.
• Pulmonary: Rales, rhonchi and wheezing
• Cardiovascular examination: Chronic respiratory insufficiency can result in pulmonary hypertension and right heart failure.
• Extremities: Digital clubbing

Laboratory Findings

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal among patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Electrocardiogram

There are no ECG findings associated with hypogammaglobulinemia.

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Surgery

Surgical intervention is not recommended for the management of [disease name].

OR

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

Surgery is the mainstay of treatment for [disease or malignancy].

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

References

Template:WikiDoc Sources